POINT Biopharma Global (PNT) Competitor Comparison
We are evaluating the key criteria listed to compare POINT Biopharma Global (PNT) against its competitors in the Biotechnology industry.
Market Capitalization
110 / 368Gross Profits
0 / 278Total Revenue
47 / 300EBITDA
15 / 337Free Cashflow
18 / 352Quick Ratio
92 / 357Earnings per Share
21 / 359Dividend yield
0 / 6Total Cash
94 / 358Performance 3 years
102 / 368Performance 5 years
126 / 368Performance 10 years
104 / 368Linearity 3 years
23 / 368Linearity 5 years
59 / 368Linearity 10 years
45 / 368Total Rank
228 / 368Dividend Rank
237 / 368Valuation Rank
9 / 368Piotroski Rank
176 / 368Muliplier Rank
180 / 368Performance 3 years - PNT ranking 102 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.